Compare Regeneron Pharmaceuticals Inc (REGN) vs Shopify Inc. (SHOP) Price & Performance

Regeneron Pharmaceuticals (REGN) trades at $739.57, down 0.34% with a bearish technical signal. The company maintains strong fundamentals with a 27.86% net income margin and consistent earnings beats. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront payments and milestone potential. Cash flow improved significantly in 2025 with $635 million net cash flow versus negative flows in prior years.

The stock presents a compelling investment case with strong profitability, positive analyst sentiment (69% buy ratings), and a $849.84 consensus price target offering 15% upside. Key risks include competitive pressures in ophthalmology drugs and reliance on key partnerships. The expanded Sanofi collaboration and promising clinical pipeline provide catalysts for growth.

Shopify trades at $164.54, down 0.84% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust revenue growth, increasing from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 111.19. Recent developments include the launch of Canvas AI store builder and strategic moves in AI-powered commerce positioning.

Outlook remains positive with 67% analyst buy ratings and $168.63 consensus target, though high valuation and competitive pressures from Amazon present risks. Operating cash flow growth to $2.4B projected for 2026 supports continued investment in merchant solutions and AI capabilities.